Two MYC-driven DLBCL cell line models, SU-DHL-4 and SU-DHL-10, were used to evaluate the enitociclib mechanism of action with IC50 values of 43 nmol/L and 74 nmol/L, respectively. Here, MYC is linked to diffuse large B-cell lymphoma.